mirtazapine has been researched along with escitalopram in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cao, L; Chen, Y; Fang, Y; Hong, W; Huang, H; Huang, Q; Kong, S; Lyu, D; Peng, D; Qian, N; Wang, F; Wei, Z; Wu, C; Wu, Z; Yang, W; Zhang, M; Zhao, J | 1 |
| Koziorowski, M; Mytych, J; Sołek, P; Tabęcka-Łonczyńska, A | 1 |
| Koziorowski, M; Mytych, J; Solek, P; Sowa-Kucma, M; Tabecka-Lonczynska, A | 1 |
| Alexandre, M; Economos, G; Glehen, O; Haesebaert, J; Perceau-Chambard, E; Subtil, F; Villeneuve, L | 1 |
| Christensen, KS; Gasse, C; Ishtiak-Ahmed, K | 1 |
1 review(s) available for mirtazapine and escitalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for mirtazapine and escitalopram
| Article | Year |
|---|---|
Difference in the regulation of biological rhythm symptoms of Major depressive disorder between escitalopram and mirtazapine.
Topics: Circadian Rhythm; Citalopram; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Mirtazapine; Treatment Outcome | 2022 |
What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol.
Topics: Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Humans; Mirtazapine; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
4 other study(ies) available for mirtazapine and escitalopram
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxetine; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Imipramine; Male; Mice; Micronuclei, Chromosome-Defective; Mirtazapine; Models, Biological; Olanzapine; Organ Specificity; Reboxetine; Reproduction; Signal Transduction; Spermatogenesis; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2; Time Factors; Venlafaxine Hydrochloride | 2021 |
Toxic effect of antidepressants on male reproductive system cells: evaluation of possible fertility reduction mechanism.
Topics: Animals; Antidepressive Agents; Escitalopram; Fertility; Genitalia, Male; Humans; Male; Mirtazapine | 2021 |
Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark.
Topics: Aged; Antidepressive Agents; Citalopram; Cross-Sectional Studies; Denmark; Depression; Escitalopram; Humans; Mirtazapine; Sertraline | 2023 |